100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human IFNAR2 Recombinant Protein (RPES1802)

SKU RPES1802
Product Type Recombinant Protein
Species Human
Application Area Cytokines & Chemokines
$210 - $471

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human IFNAR2 Recombinant Protein

Interferon ?/β Receptor 2 (IFN-?/β R2) is a single-pass type I membrane protein which belongs to the type II cytokine receptor family. It complexes with IFN-?/β R1 to form the signaling receptor complex for the family of ? and β IFN subtypes. By alternative splicing; IFN-?/β R2 can exist as a secreted soluble protein or as a type I membrane protein. IFN-?/β R2 is the principal ligand binding subunit of the receptor. Ligand binding is stabilized by the subsequent association with IFN-?/β R1; resulting in the formation of a signaling ternary receptor complex. IFNAR2 was detected in most lymphocytes; monocytes; and granulocytes; although IFNAR2 expression was higher in the monocytes and granulocytes than in the lymphocytes. Among the lymphocyte subsets; IFNAR2 showed high expression in natural killer (NK) cells and low expression in T lymphocytes. Isoform 1 and isoform 3 of IFNAR2 are directly involved in signal transduction due to their interaction with the TYR kinase; JAK1. Isoform 1 also interacts with the transcriptional factors; STAT1 and STAT2. Both forms are potent inhibitors of type I IFN activity.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose